| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5878480 | The American Journal of Medicine | 2014 | 6 Pages |
Abstract
The risks and benefits of primary thromboprophylaxis with anticoagulant therapy in hospitalized patients with cancer are not known. This is especially relevant because numerous Medicare-type pay-for-performance incentives mandate prophylaxis specifically in patients with cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Marc MD, MSc, Alok A. MD, Patricia MD, Grégoire MD, PhD, Rebecca MD, Jeffrey I. MD,